Dr. Mandri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8785 SW 165th Ave
Ste 200
Miami, FL 33193Phone+1 786-554-0008Fax+1 786-209-2160
Education & Training
- University of Miami/Jackson Health SystemResidency, Psychiatry, 1980 - 1983
- Advocate Health Care/Advocate Christ Medical CenterInternship, Internal Medicine, 1979 - 1980
- Universidad Central del Este Facultad de MedicinaClass of 1977
Certifications & Licensure
- FL State Medical License 1979 - 2026
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Physician's Recognition Award American Medical Association
- Certificate of Commendation Mental Health Association of Dade County
- Certificate of Appreciation for Exemplary Service Admission Committee Herbert. Wertheim College of Medicine Florida International University
Publications & Presentations
PubMed
- 97 citationsNBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled studyChristopher F. O'Brien, Roland Jimenez, Robert A. Hauser, Stewart A. Factor, Joshua Burke
Movement Disorders. 2015-10-01
Research History
- Principal investigatorProtocol xxxxx: A study to assess effectiveness, safety and health related outcomes of xxxxx for the treatment of Pseudobulbar affect in nursing home patients.
- Principal InvestigatorProtocol xxxxx: A phase III, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of xxxxx for the treatment of agitation in patients with dementia of the Alzheimer’s type.
- Principal investigatorProtocol xxxxx: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel, Fixed-Dose Study to Assess the Efficacy, Safety, and Tolerability of xxxxx for the Treatment of Tardive Dyskinesia.
Professional Memberships
- American Psychiatric AssociationFellow
- The New York Academy of ScienceMember
- The Royal Society of MedicineMember
- World Psychiatric AssociationMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: